Dow Up1.13% Nasdaq Up1.41%

Vertex Pharmaceuticals Incorporated (VRTX)

-NMS
112.64 Up 1.79(1.61%) 3:59PM EDT
|After Hours : 112.64 0.00 (0.00%) 4:45PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (445,028) (107,032) 29,574  
Operating Activities, Cash Flows Provided By or Used In
Depreciation48,365  38,191  53,450  
Adjustments To Net Income592,666  292,602  241,270  
Changes In Accounts Receivables53,363  39,912  (170,606)
Changes In Liabilities(53,495)1,815  79,472  
Changes In Inventories7,142  (29,925)(111,388)
Changes In Other Operating Activities(12,061)(23,619)10,358  
Total Cash Flow From Operating Activities (51,570) 267,841   143,735  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(51,393)(71,140)(34,595)
Investments(64,123)(337,902)294,495  
Other Cash flows from Investing Activities61,386  (16,775)(47,488)
Total Cash Flows From Investing Activities (54,130) (425,817) 212,412  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock265,878  191,721  124,862  
Net Borrowings(83,742)(21,488)(155,000)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 180,884   172,204   (124,238)
Effect Of Exchange Rate Changes4,708  (141)214  
Change In Cash and Cash Equivalents 79,892   14,087   232,123  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.